Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI

PHASE3RecruitingINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

February 22, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2031

Conditions

Neurocognitive Dysfunction

Interventions

DRUG

Memantine Oral Tablet

Drug to preserve memory and neurocognitive dysfunction induced by radiation therapy

Trial Locations (1)

RECRUITING

Tata Memorial Hospital, Mumbai

All Listed Sponsors

lead

Tata Memorial Centre

OTHER